Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
106-120 of 4402 results
UIC researchers identify new way to inhibit major cancer gene
By PBR Staff Writer
Researchers at the University of Illinois at Chicago in the US have discovered a monobody that can block the oncogene’s activity.
Drug Research > Drug Discovery & Development > News
Nestle invests $145m in biopharmaceutical firm Aimmune Therapeutics
By PBR Staff Writer
Nestle Health Science is investing $145m for a 15% stake in Aimmune Therapeutics, a clinical-stage biopharmaceutical firm which develops treatments for people with life-threatening food allergies.
Drug Research > Drug Discovery & Development > News
Researchers engineer antimicrobial peptide to kill bacteria
By PBR Staff Writer
A team of researchers has developed a new weapon intended for taking down bacteria that are becoming increasingly resistant to existing antibiotics.
Drug Research > Drug Discovery & Development > News
Turnstone Biologics raises $41.4m to advance cancer immunotherapy
By PBR Staff Writer
Canada-based oncolytic viral immunotherapies developer Turnstone Biologics has raised $41.4m in a Series B venture financing.
Drug Research > Drug Discovery & Development > News
Astellas to acquire Ganymed Pharmaceuticals in EUR1.28bn deal
By PBR Staff Writer
Japan’s Astellas Pharma has agreed to acquire Germany-based Ganymed Pharmaceuticals in a deal that could potentially reach €1.28bn.
Drug Research > Drug Discovery & Development > News
Allergan exercises option to buy Motus Therapeutics
By PBR Staff Writer
Allergan has exercised its option to acquire Motus Therapeutics, a biopharmaceutical firm engaged in the development of peptide therapeutics to treat gastrointestinal (GI) diseases.
Drug Research > Drug Discovery & Development > News
Inositec secures $1.42m financing to advance new class of inositol hexaphosphate-based drug candidates
Inositec, which is engaged in the development of life-saving small molecule drugs based on inositol hexaphosphate (IP6), has closed a CHF1.4m ($1.42m) seed financing.
Drug Research > Drug Discovery & Development > News
GSK partners with Fimbrion to develop UTI drug
By PBR Staff Writer
GlaxoSmithKline (GSK) has partnered with US life sciences firm Fimbrion Therapeutics for the development of a small molecule drug to treat prevent urinary tract infections (UTIs).
Drug Research > Drug Discovery & Development > News
Debiopharm reaches key development milestones for Staphylococcus-selective antibiotic Debio 1450
Debiopharm International has announced various significant achievements in the development of its new antibiotic Debio 1450, selectively active on staphylococcal species including hard-to-treat methicillin-resistant Staphylococcus aureus (MRSA).
Drug Research > Drug Discovery & Development > News
NBE Therapeutics, Sotio partner to develop next-generation antibody-drug conjugates
NBE Therapeutics and Sotio have partnered to develop next-generation antibody-drug conjugates (ADCs) for improved cancer therapy.
Drug Research > Drug Discovery & Development > News
Redx Pharma identifies drug development candidate for leukaemia program
Redx Pharma has identified a drug development candidate for its reversible Bruton’s Tyrosine Kinase (BTK) inhibitor program.
Drug Research > Drug Discovery & Development > News
Sun Pharma, ICGEB partner to develop dengue vaccine
Drugmaker Sun Pharmaceutical Industries has partnered with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new dengue vaccine.
Drug Research > Drug Discovery & Development > News
Domain Therapeutics creates new company to stop Parkinson’s disease progression
France-based biopharmaceutical firm Domain Therapeutics has established a new company, Mavalon Therapeutics, dedicated to develop a drug candidate to stop the progression of Parkinson’s disease.
Drug Research > Drug Discovery & Development > News
Antegrin and Cascadia merge to form Indalo Therapeutics
Antegrin Therapeutics and Cascadia Therapeutics have established Indalo Therapeutics, a biotechnology company dedicated to developing novel therapies to treat fibrotic diseases.
Drug Research > Drug Discovery & Development > News
Sofinnova closes latest venture capital fund at $650m
Biotech-focused investment company Sofinnova has closed Sofinnova Venture Partners X at its hard cap of $650m.
Drug Research > Drug Discovery & Development > News
106-120 of 4402 results